Paychex received divergent analyst actions on June 25, with JPMorgan raising its price target to $105 from $100 while maintaining an Underweight rating, and UBS trimming its target to $98 from $100 with a Neutral rating. JPMorgan cited solid fourth-quarter results, while UBS pointed to the company's inaugural fiscal year 2027 guidance of 5 to 6 percent total revenue growth, which fell short of market expectations for stronger growth driven by cross-selling and larger deals. UBS also highlighted the HUB alliance impact and the WISE Workforce Intelligence announcement as potential future revenue drivers. Paychex, a provider of human capital management solutions, reported an operating margin of 38.32 percent.
Paychex IncMixed analyst actions: JPMorgan raised PT but maintains Underweight; UBS trimmed PT with Neutral, citing FY2027 guidance below expectations.